Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Kenanga Investment Bank Introduces World’s First Hang Seng Biotech Index Structured Warrants to Malaysia
3+ day, 13+ hour ago (610+ words) Asia News Network KUALA LUMPUR, MALAYSIA – – 10 September 2026 – Kenanga Investment Bank Berhad (“Kenanga Group” or “The Group“) is proud to unveil the world’s first structured warrants linked to the Hang Seng Biotech Index (“HSBIO“) under its flagship brand, NagaWarrants by Kenanga…...
Kenanga Investment Bank Introduces Worldâs First Hang Seng Biotech Index Structured Warrants to Malaysia | News | voiceofalexandria.com
4+ day, 11+ hour ago (927+ words) Kenanga Investment Bank Introduces World’s First Hang Seng Biotech Index Structured Warrants to Malaysia Voice of Alexandria...
Kenanga Investment Bank Introduces World???s First Hang Seng Biotech Index Structured Warrants to Malaysia
4+ day, 11+ hour ago (185+ words) HSBIO tracks 30 of the largest biotechnology and healthcare companies listed in Hong Kong. In 2025, the index gained 64.5%, significantly outperforming the HSI, HSCEI and HSTECH. During the year, the index rose by more than 80% at its peak, reflecting rising investor interest…...
Huons Global ends Huons–Huons Lab merger amid shareholder revolt in Korea
2+ week, 5+ day ago (304+ words) Board scraps vote as special committee cites policy shifts, valuation disputes and share slide, pledging focus on R&D and shareholder trust The merger between subsidiary Huons Lab and Huons(243070), which Huons Global(084110) had been pursuing, has been called off....
Shao-Lee Lin Discloses Investment at Cue Biopharma with 6.2% Stake
3+ week, 2+ day ago (187+ words) TradingView Shao-Lee Lin Discloses Investment at Cue Biopharma with 6.2% Stake Shao-Lee Lin, President and CEO of Cue Biopharma, Inc., disclosed a 6.2% beneficial stake in the company’s common stock. The filing dated Aug. 21, 2026 details equity grants tied to her appointment and…...
Venue G's Four-Year Control Battle Ends as 'Super Ant' Bae Jin-han Shifts to Passive Investment — BigGo Finance
3+ week, 3+ day ago (276+ words) Bae's relationship with Venue G dates back to 2022. In April of that year, he disclosed a 6.05% stake in Venue G, and the following year he changed the stated purpose of his holdings to "influence over management," launching his shareholder activism…...
Koh Brothers Eco Engineering Discloses $57.6M Legal Exposure Amid Mainboard Transfer Bid
3+ week, 6+ day ago (232+ words) The legal challenges primarily involve the company’s subsidiary, Koh Brothers Building & Civil Engineering Contractor (KBCE). The firm detailed three distinct areas of conflict: a joint venture (JV) dispute with a maximum exposure of S$20.5 million, a consortium arbitration involving S…...
Sam Chun Dang ends Eylea patent fights with global settlements
3+ week, 6+ day ago (12+ words) CHOSUNBIZ Chosunbiz...